Adherence to Pharmacological Guidelines of Cardiothoracic Surgeons is associated with Re- hospitalizations and with 1 and 8-year Mortality after Coronary Artery Bypass Graft (CABG) Surgery

Keren Laufer 1 Liraz Olmer 2 Arnona Ziv 2 Amnon Zlotnick 3 Amir Elami 3 Rachel Dankner 1,2
1Department of Epidemiology and Public Health, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv
2Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan
3Department of Cardiothoracic Surgery, Lady Davis Carmel Medical Center, Haifa
Background: The American College of Cardiology and The American Heart Association publish specific guidelines for cardiac patients after CABG surgery. These guidelines recommend prescription of anti platelet-aggregants, beta blockers and lipid-lowering medications as a standard therapy for all patients after the surgery.

Objectives: To study the association between adherence to pharmacological guidelines of the discharging cardiac surgeon and prognostic factors of the cardiac patient during first year and 8 years after CABG surgery.

Subjects and Methods: In this prospective study a total of 1132 cardiac patients from 7 medical centers in Israel operated during 2004-2007 were followed since surgery up to 8 years for vital status. Recommended medications were recorded from the letter of discharge. A 1-year follow-up home interview included detailed information on re-hospitalizations and medication use.

Results: Anticoagulants, beta blockers and lipid lowering medications were recommended in 95.5%, 76.6% and in 73.5% of all patients' letter of discharge respectively. One year re-hospitalization rate was 29.6% compared to 46.2% for adherence and non-adherence patients respectively. Multivariate regressions adjusting for propensity score ,summary of SF-36 QoL, years of education and Charlson's co-morbidity index showed that patients who were recommended to receive all three drugs (adherence-patients) had a 22-23% lower risk for re-hospitalization or mortality than non-adherence patients (OR = 0.781, 95%CI: 0.59-1.03, p = 0.076).  In addition, Kaplan Meier model showed better survival in adherence-patients (Log Rank P<0.001). Finally, an adjusted Cox's regression model showed that the 8-year mortality risk in adherence-patients was 31.4% lower (HR=0.686, 95%CI: 0.51-0.93, p = 0.015).

Conclusions: Cardiac patients would benefit from adherence of the cardiothoracic physician to medical guidelines in terms of reduced re-hospitalizations and all-cause mortality. Cardiothoracic surgeons should be encouraged to recommend these medications to cardiac patients after CABG surgery in the letter of discharge.









Powered by Eventact EMS